Close Menu

ADME screen

The federal court order dismissed the case with prejudice, which prevents the plaintiffs from raising the case again.

The effort is already bearing fruit, as the team has been able to validate several variants known to be connected with adverse drug reactions.

NEW YORK (GenomeWeb News) – Agilent Technologies announced that it and a team of researchers from six organizations are developing models for toxicology testing with a $6 million grant from the National Institutes of Health.

RainDance is partnering with Roche 454 and Ambry in two separate alliances aimed at developing ADME gene screening panels for use on next-generation sequencing instruments.

The partners aim to develop a transporter-based assay system capable of predicting absorption, distribution, metabolism, and excretion of drug candidates.

The lawsuit claims that Invitrogen and CellzDirect are infringing a Celsis patent that relates to processes and methods for producing cryopreserved hepatocytes.

The Seoul-based life sciences firm will provide an array of services to help develop biological assays for cancer and endocrine disorders.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.